A Smarter Way To Get New Clients

Learn the Secrets of Finance and Sell More

AstraZeneca and Bristol Myers Squibb Discuss Potential $400 Billion Megadeal

AstraZeneca and Bristol Myers Squibb have held preliminary discussions regarding a potential merger that could create a pharmaceutical giant valued…

Analysis

PC Makers, Microsoft, and Investors Capitalize on the Great PC Resurgence

Analysis

UK’s Review of McCormick/Unilever Will Test Remedies and Tax Benefits

News

AstraZeneca and Bristol Myers Squibb Discuss Potential $400 Billion Megadeal

News

Bidding War for EasyJet Reaches Final Stage as Timelines Align

News

Romania Fines Sugar Producers €10M Over Price-Fixing

News

Sandoz Agrees to $478.5 Million Settlement to Resolve U.S. Generic Drug Antitrust Litigation

News

Polish Regulatory Body Fines Agricultural Equipment Cartel

News

LATEST ANALYSIS

Analysis

UK’s Review of McCormick/Unilever Will Test Remedies and Tax Benefits

Analysis

Uber-Delivery Hero Are Carving-Out Unprofitable Businesses, Good for Firms, Not for Regulators

Analysis

The Financial and Antitrust Realities of the €20 Billion Bouygues-Orange-Iliad Deal

Analysis

Netflix Will Stream The Next World Cup in 2027 And May Not Stop There

Analysis

UniCredit’s Checkmate against Commerzbank Shows the Way for EU Banking Consolidation

Analysis

CMA Plays Investor in ABF/Hovis

FINANCE FOR LAWYERS

Finance For Lawyers

Did the UK Court of Appeals Make Excessive Pricing Claims Easier?

In Pfizer/Flynn (Phenytoin II), the Court of Appeal closed one of UK…

Finance For Lawyers

EBITDA vs. Adjusted EBITDA

For a long time, before we created Antitrust Intelligence, these two terms…

Finance For Lawyers

What the Lufthansa State Aid Case Teaches Lawyers About Finance

Germany bailed out Lufthansa with €6 billion during COVID. Ryanair and Condor…

Finance For Lawyers

How Private Equity Will Determine CMA’s Remedies in Dental Study

The CMA’s recent launch of a market study into the dental services…

Antitrust Intelligence

A Smarter Way To Get New Clients

AstraZeneca and Bristol Myers Squibb Discuss Potential $400 Billion Megadeal

PC Makers, Microsoft, and Investors Capitalize on the Great PC Resurgence

UK’s Review of McCormick/Unilever Will Test Remedies and Tax Benefits

News

AstraZeneca and Bristol Myers Squibb Discuss Potential $400 Billion Megadeal

Bidding War for EasyJet Reaches Final Stage as Timelines Align

Romania Fines Sugar Producers €10M Over Price-Fixing

Sandoz Agrees to $478.5 Million Settlement to Resolve U.S. Generic Drug Antitrust Litigation

Polish Regulatory Body Fines Agricultural Equipment Cartel

LATEST ANALYSIS

UK’s Review of McCormick/Unilever Will Test Remedies and Tax Benefits

Uber-Delivery Hero Are Carving-Out Unprofitable Businesses, Good for Firms, Not for Regulators

The Financial and Antitrust Realities of the €20 Billion Bouygues-Orange-Iliad Deal

Netflix Will Stream The Next World Cup in 2027 And May Not Stop There

UniCredit’s Checkmate against Commerzbank Shows the Way for EU Banking Consolidation

CMA Plays Investor in ABF/Hovis

FINANCE FOR LAWYERS

Did the UK Court of Appeals Make Excessive Pricing Claims Easier?

EBITDA vs. Adjusted EBITDA

What the Lufthansa State Aid Case Teaches Lawyers About Finance

How Private Equity Will Determine CMA’s Remedies in Dental Study

Cookie Policy

Terms & Conditions

Privacy Policy

Contact

Antitrust Intelligence

A Smarter Way To Get New Clients

News

LATEST ANALYSIS

FINANCE FOR LAWYERS

7 Days Free Access